Navin Fluorine International Limited has informed the Exchange about Schedule of meet and Presentation
NAVINFLUOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Navin Fluorine informed the exchanges about a scheduled analyst/institutional investor meeting on May 30, 2025, at the B&K Securities Trinity India 2025 conference, along with its latest investor presentation. For FY25 (consolidated), the company reported sales of Rs. 2,349.4 Cr (+14% YoY), operating EBITDA of Rs. 533.7 Cr (+34% YoY) with margins expanding 343 bps to 22.7%, and operating PBT of Rs. 336.4 Cr (+48% YoY). Q4FY25 was particularly strong with sales of Rs. 700.9 Cr (+16% YoY), EBITDA of Rs. 178.7 Cr (+62% YoY) at 25.5% margin, and PBT of Rs. 115.2 Cr (+72% YoY). The CDMO vertical surged 141% YoY in Q4, while HPP grew 10% and Specialty Chemicals was flat. Key updates include the AHF plant (Rs. 450 Cr) commissioning in Q2 FY26, cGMP4 Phase 1 (Rs. 160 Cr of Rs. 288 Cr) by Q3 FY26, and a new Chemours partnership for AI data center cooling fluids expected operational in Q1 FY27.
This is a routine disclosure of an investor conference with the company's detailed FY25 results presentation. The strong Q4FY25 margin expansion and CDMO growth may be viewed positively by investors, while upcoming capacity commissioning and the Chemours partnership signal future growth visibility.